Publications by authors named "Fabienne Hermitte"

Claim this Profile
C
Comparison of Immune Response Assessment in Colon Cancer by Immunoscore (Automated Digital Pathology) and Pathologist Visual Scoring.
Isabelle Boquet, Alboukadel Kassambara, Alfred Lui, Alicia Tanner, Marie Latil, Fabienne Hermitte

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors.
James Spicer, Aurélien Marabelle, Jean-Francois Baurain, Nina Louise Jebsen, Dag Erik Jøssang, Fabienne Hermitte

Clin Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer.
Alessandro Ottaiano, Michele Caraglia, Annabella Di Mauro, Gerardo Botti, Angela Lombardi, Fabienne Hermitte

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer.
Frank A Sinicrope, Qian Shi, Fabienne Hermitte, Tyler J Zemla, Bernhard Mlecnik

JNCI Cancer Spectr· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer.
Florence Marliot, Xiaoyi Chen, Amos Kirilovsky, Thomas Sbarrato, Carine El Sissy, Fabienne Hermitte

J Immunother Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer.
Alessandro Ottaiano, Luisa Circelli, Angela Lombardi, Stefania Scala, Nicola Martucci, Fabienne Hermitte

Cell Death Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy.
Marieke E IJsselsteijn, Rebeca Sanz-Pamplona, Fabienne Hermitte, Noel F C C de Miranda

Mol Aspects Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers immune monitoring technology primer: Immunoscore® Colon.
Fabienne Hermitte

J Immunother Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer.
François Bertucci, Nathalie Borie, Henri Roche, Thomas Bachelot, Jean-Marc Le Doussal, Fabienne Hermitte

Breast Cancer Res Treat· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2V617F does not mean absence of myeloproliferative neoplasm.
Hélène Peyro-Saint-Paul, Fabienne Hermitte

Blood· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
Daniela Cilloni, Aline Renneville, Fabienne Hermitte, Robert K Hills, Sarah Daly

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How basal are triple-negative breast cancers?
François Bertucci, Pascal Finetti, Nathalie Cervera, Benjamin Esterni, Fabienne Hermitte

Int J Cancer· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EQUAL-quant: an international external quality assessment scheme for real-time PCR.
Simon C Ramsden, Sarah Daly, Wolf-Jochen Geilenkeuser, Graeme Duncan, Fabienne Hermitte

Clin Chem· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and validation of an ERBB2 gene expression signature in breast cancers.
François Bertucci, Nathalie Borie, Christophe Ginestier, Agnès Groulet, Emmanuelle Charafe-Jauffret, Fabienne Hermitte

Oncogene· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis